Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

90.38
Delayed Data
As of May 27
 +1.19 / +1.33%
Today’s Change
75.90
Today|||52-Week Range
143.45
-28.17%
Year-to-Date

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 110.00, with a high estimate of 155.00 and a low estimate of 75.00. The median estimate represents a +21.71% increase from the last price of 90.38.

Analyst Recommendations

The current consensus among 26 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.22
Sales
$429.0M
Reporting Date
Jul 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 145.56%
 
 
 
 
 
 
Growthannually 199.74%
 
 
 
 
 
 

Sales

Growthquarterly 7.76%
 
 
 
 
 
 
Growthannually 74.30%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.